Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ

Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes, Antonio C. Wolff, M. Elizabeth H. Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, Donald C. Allred, John M.S. Bartlett, Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Archives of Pathology & Laboratory Medicine. ,vol. 138, pp. 241- 256 ,(2014) , 10.5858/ARPA.2013-0953-SA

Yoshifumi Komoike, Futoshi Akiyama, Yuichi Iino, Tadashi Ikeda, Sadako Akashi-Tanaka, Shozo Ohsumi, Mikihiro Kusama, Muneaki Sano, Eisei Shin, Kimito Suemasu, Hiroshi Sonoo, Tetsuya Taguchi, Tsunehiro Nishi, Reiki Nishimura, Shunsuke Haga, Keiichi Mise, Takayuki Kinoshita, Shigeru Murakami, Masataka Yoshimoto, Hideaki Tsukuma, Hideo Inaji, Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer. ,vol. 106, pp. 35- 41 ,(2006) , 10.1002/CNCR.21551

Melvin J Silverstein, The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast The American Journal of Surgery. ,vol. 186, pp. 337- 343 ,(2003) , 10.1016/S0002-9610(03)00265-4

Bernard Fisher, James Dignam, Norman Wolmark, D Lawrence Wickerham, Edwin R Fisher, Eleftherios Mamounas, Roy Smith, Mirsada Begovic, Nikolay V Dimitrov, Richard G Margolese, Carl G Kardinal, Maureen T Kavanah, Louis Fehrenbacher, Robert H Oishi, None, Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial The Lancet. ,vol. 353, pp. 1993- 2000 ,(1999) , 10.1016/S0140-6736(99)05036-9

Shaoxi Liao, Mohamed M. Desouki, Daniel P. Gaile, Lori Shepherd, Norma J. Nowak, Jeffrey Conroy, William T. Barry, Joseph Geradts, Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. Genes, Chromosomes and Cancer. ,vol. 51, pp. 1067- 1078 ,(2012) , 10.1002/GCC.21991

Salomone Di Saverio, Fausto Catena, Donatella Santini, Luca Ansaloni, Tommaso Fogacci, Stefano Mignani, Antonio Leone, Filippo Gazzotti, Stefano Gagliardi, Angelo De Cataldis, Mario Taffurelli, 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up Breast Cancer Research and Treatment. ,vol. 109, pp. 405- 416 ,(2008) , 10.1007/S10549-007-9668-7

Shi-Yi Wang, Tatyana Shamliyan, Beth A. Virnig, Robert Kane, Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis Breast Cancer Research and Treatment. ,vol. 127, pp. 1- 14 ,(2011) , 10.1007/S10549-011-1387-4

Robert J. Rosser, Consensus conference on the classification of ductal carcinoma in Situ Cancer. ,vol. 82, pp. 2293- 2294 ,(1998) , 10.1002/(SICI)1097-0142(19980601)82:11<2293::AID-CNCR29>3.0.CO;2-O

Jianguang Ji, Kari Hemminki, Risk for contralateral breast cancers in a population covered by mammography : effects of family history, age at diagnosis and histology Breast Cancer Research and Treatment. ,vol. 105, pp. 229- 236 ,(2007) , 10.1007/S10549-006-9445-Z

Harold J. Burstein, Kornelia Polyak, Julia S. Wong, Susan C. Lester, Carolyn M. Kaelin, Ductal Carcinoma in Situ of the Breast The New England Journal of Medicine. ,vol. 350, pp. 1430- 1441 ,(2004) , 10.1056/NEJMRA031301